Focus Issue on Prevention
Issue @ A Glance
Risk assessement and its management: from SCORE to statins, ezetimibe to PCSK inhibitors
CardioPulse
Basic Science and Cardiology I: Basics
Basic Science and Cardiology II: Funding
Andreas Baumbach MD FESC FRCP
My 10th TAVI Anniversary
Delirium in cardiac patients
Current Opinion
European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk
Editorial
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: comparing and contrasting guidance across the Atlantic
Limitations of the SCORE-guided European guidelines on cardiovascular disease prevention
Clinical Research
Coronary artery disease
Low-density lipoprotein cholesterol targeting with pitavastatin + ezetimibe for patients with acute coronary syndrome and dyslipidaemia: the HIJ-PROPER study, a prospective, open-label, randomized trial
Editorial
Reduction of LDL-C-related residual cardiovascular risk with ezetimibe: are mechanistic considerations warranted in practice?
Heart failure/cardiomyopathy
Effect of vitamin D on all-cause mortality in heart failure (EVITA): a 3-year randomized clinical trial with 4000 IU vitamin D daily
Editorial
Vitamin D supplementation in heart failure: case closed?
Prevention and epidemiology
Long-term exposure to road traffic noise, ambient air pollution, and cardiovascular risk factors in the HUNT and lifelines cohorts
Editorial
Environmental stressors and cardiovascular disease: the evidence is growing
Hypertension
Risk for hypertension crosses generations in the community: a multi-generational cohort study
Editorial
Understanding the role of genetics in hypertension
Cardiovascular Flashlights
Primary echinococcus infection of the heart: a rare type of cystic echinococcosis
Large multiple tuberous xanthomas presenting with severe coronary artery disease
- CME
-
Cover Image
Cover Image
Primary echinococcus infection of the heart: a rare type of cystic echinococcosis
T.N.C. Padmanabhan, K.V.K. Kumar, Mohammed Sadiq Azam*, and Anil Kumar Bilolikar
Krishna Institute of Medical Sciences, 1-8-31/1, Minister Road, Secunderabad 500003, Telangana, India
* Corresponding author. Tel: +91 9177618108, Email: drmdsadiq@gmail.com
A 45-year-old Indian soldier, recently diagnosed hypertensive, underwent 2D transthoracic echocardiography as part of his evaluation, which revealed a large cystic mass in the right ventricle (RV) attached to the interventricular septum (IVS) (Panel A). The cystic appearance with multiple septations giving it a cartwheel like appearance due to the presence of daughter cysts within was suggestive of a diagnosis of cystic echinococcosis (CE) of the heart. Serology was positive for Echinococcus granulosus antibody. A magnetic resonance imaging (MRI) scan was done which showed a round, sharply demarcated encapsulated cystic mass with multiple internal septations, attached to the IVS on the RV side and tethered to the septal leaflet of the tricuspid valve measuring 4.1 × 3.3 cm in size. The appearance was consistent with a diagnosis of CE WHO stage CE2 (Panel B). MRI did not detect any other cystic lesions elsewhere in the body. The patient was initiated on Albendazole therapy in view of positive serology test, followed by cyst excision via a right atrial approach (black arrow, Panel C). The excised cyst had 13 daughter cysts within (Panel D) and microscopic examination of an unstained wet mount of the excised cystic fluid demonstrated protoscolices of E. granulosus (Panel E) leading to a definitive diagnosis of CE. He is doing well at 3 months follow-up. Cardiac echinococcosis is a rare manifestation of CE with a reported prevalence of 0.5–2%. Treatment depends on WHO stage which in this case warranted complete surgical removal with adjunctive medical therapy.
- Front Matter
- Table of Contents


